Moffitt logo

Clinical Trials Search

Clinical Trial 19002

Cancer Type: Healthy Subjects
Study Type: Prevention
NCT#: NCT03404596

Phase: N/A
Prinicipal Investigator:

Call 813-745-6100
or 1-800-679-0775 Learn More

Study Title

Applying mHealth to Tobacco-related Health Disparities: Enhancing Aspects of Resiliency to Aid Cessation Efforts


The purpose of this study is to better understand what happens when someone attempts to quit smoking.


Aim 1: Examine pathways linking state mindfulness (measured in real-time in the real-world via EMA) to cessation (via AutoSense) with a longitudinal cohort study of a racially/ethnically diverse smokers. Key mechanisms are: PA (via EMA), NA (via EMA and AutoSense), and SRC (via AutoSense). H1: Higher state mindfulness will be associated with: a) higher PA, b) lower NA, c) greater SRC, and d) a reduced likelihood of lapsing. H2: Higher levels of state mindfulness will moderate the relationships of: a) Specific events and subsequent affective response, with higher mindfulness strengthening the link between restoring events and increased PA, and weakening the link between depleting events and increased NA. b) Affect and SRC, such that higher mindfulness will strengthen the relationship between increased PA and higher SRC and weaken the relationship between increased NA and reduced SRC. Aim 2: Conduct a feasibility study to evaluate the potential efficacy of providing real-time, real-world mindfulness intervention strategies among a sample of racially/ethnically diverse smokers (original data collection). H3: Providing a mindfulness strategy to be used in real-time will be associated with: a) lower NA, b) greater SRC, and c) a reduced likelihood of lapsing.




Inclusion Criteria

  • Smoked a minimum of 3 cigarettes per day over the past year
  • Expired carbon monoxide reading ≥ 6
  • Motivated to quit within the next 30 days
  • Valid home address
  • Functioning telephone number
  • Can speak, read, and write in English
  • At least marginal health literacy

  • Exclusion Criteria

  • Contraindication for the nicotine patch (e.g., heart attack, angina, skin allergies) unless a doctor's note is provided
  • Endorse current psychosis
  • Have a pacemaker or implanted device
  • Physically unable to wear equipment and provide a good reading of physiological measures
  • Current use of tobacco cessation medications
  • Current use of smoking products other than cigarettes and e-cigarettes
  • Involvement in a smoking program or currently trying to quit
  • Pregnancy or lactation
  • Another household member being enrolled in the study
  • No prior experience with a smart phone
  • The study staff or principal investigator (PI) have serious concerns about the participant's ability to engage in and/or complete the study protocol.

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.